Transamerica Life Insurance Fit Review for Sleep Apnea

Research Snapshot

Why Transamerica Qualified for This Study

Questions This Section Answers

• Is Transamerica a good choice for life insurance if I have sleep apnea?
• Why did AI platforms include Transamerica in sleep apnea life insurance rankings?

Transamerica qualified because it is one of the few carriers whose own published underwriting materials name sleep apnea directly and assign potential risk-class outcomes by severity. Transamerica's medical-impairment guide lists mild sleep apnea as potentially Standard, moderate as Standard to Table 3, and severe as Table 2 to decline, while stating that actual offers vary by age, diagnosis date, and severity ^[4]. A separate Transamerica field underwriting guide cited by Google repeats the same mild/moderate/severe structure ^[5].

Independent reviewers reinforce the inclusion. Policygenius names Transamerica a top option for mild sleep apnea with well-controlled symptoms and a normal height-to-weight ratio ^[6]. Mozdex describes Transamerica's build chart as among the most generous and says the carrier underwrites controlled sleep apnea more reasonably than many competitors ^[8].

The ranking-stage description also referenced "20–40 year term options" and a "Transamerica Foundation Series" product. Neither was verified in the reviewed sources: Transamerica materials list 10-, 15-, 20-, 25-, and 30-year initial level-premium periods for Trendsetter Super, and no reviewed source established Foundation Series as the most relevant term product for this use case ^[9].

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Sleep Apnea

Questions This Section Answers

• Which Transamerica plan should a buyer with sleep apnea choose: Trendsetter Super or Trendsetter LB?
• Does Transamerica Trendsetter Super offer no-medical-exam coverage for sleep apnea applicants?

Trendsetter Super is the most consistently identified Transamerica product for this use case across platforms. It is a term life product with initial level-premium periods of 10, 15, 20, 25, or 30 years, a conversion privilege, and simplified-issue availability for qualifying configurations ^[12]. Trendsetter LB is the alternative where living benefits are desired; it includes chronic, critical, and terminal illness riders at no additional premium, but one independent review describes the LB series as stricter in underwriting than Trendsetter Super ^[16].

No-medical-exam availability is the most repeated product claim. Multiple independent reviews state Trendsetter Super allows up to $2 million without a medical exam for qualifying applicants ^[18]. Transamerica's own term life page states simplified underwriting with no medical exam up to $2 million for qualified applicants ^[22]. However, a Trendsetter Super product bulletin states non-med underwriting is only available on standard risk classes and within age and face-amount limits — one bulletin cites $25,000 to $99,999 for ages 18 to 60 and $25,000 to $50,000 for ages 61 to 70 ^[24]. Those limits conflict with the broader $2 million figure, and the reviewed sources do not reconcile them.

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about Transamerica for sleep apnea life insurance?
• Does Transamerica underwrite controlled sleep apnea more favorably than other carriers?

Platforms broadly agreed on four points.

First, Transamerica treats sleep apnea as an underwritten condition rather than an automatic decline. Transamerica's underwriting primer asks for sleep-study date and results, and its medical-impairment guide assigns severity-based outcomes ^[26].

Second, documented treatment compliance improves outcomes. Independent 2026 guidance identifies severity, AHI, treatment compliance, and overall health as major underwriting factors ^[29]. Mozdex states documented CPAP compliance with a follow-up sleep study showing controlled apnea can yield Standard or better rates, and that Transamerica wants treatment adherence rather than perfection ^[31]. One Transamerica guide indicates sleep apnea with good CPAP response can be Standard after 6+ months ^[33].

Third, term structure is flexible. Platforms consistently cite 10- to 30-year term options and conversion to permanent coverage without new medical underwriting ^[34].

Fourth, financial strength is solid. Transamerica holds an A (Excellent) rating from AM Best per multiple independent reviews ^[37]. One 2025 source cited by Anthropic states A+ (Superior) instead, and the reviewed sources do not resolve the discrepancy — buyers should confirm the current rating directly.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Is Transamerica's sleep apnea underwriting transparent enough to predict my rate class?
• How do AI platforms disagree on Transamerica's fit for severe sleep apnea?

Fit ratings split: four platforms rated Transamerica "good" (anthropic, google, kimi, openai) and three rated it "mixed" (deepseek, grok, perplexity). The disagreement is not about whether Transamerica accepts sleep apnea applicants — it is about how predictable and how competitive the outcome is.

Deepseek reported that Transamerica's public materials do not mention sleep apnea underwriting guidelines at all, making eligibility and pricing hard to predict ^[40]. That finding conflicts with OpenAI, Google, and Perplexity, which located Transamerica documents that do address sleep apnea ^[41]. Deepseek's research was also conducted without search enabled and dated 2026-01-15, eight months before the run date — a material freshness gap.

Grok reported that Transamerica is more conservative than peers on top rate classes, and that mild cases seeking Preferred Plus rates may do better at Protective or similar carriers ^[44]. Kimi similarly noted that severe cases (AHI 30+) are not where Transamerica is highlighted as a specialist ^[45].

Unresolved items across platforms: the exact CPAP-adherence rule, the AHI cutoff for each rate class, whether a 40-year term exists, whether Foundation Series is relevant here, and whether the $2 million no-exam ceiling or the much lower bulletin limits apply to a given applicant.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What underwriting factors does Transamerica use for sleep apnea life insurance applicants?
• Does Transamerica Trendsetter Super include living benefits or conversion for sleep apnea buyers?

Transamerica's underwriting assessment for sleep apnea centers on severity, sleep-study results, treatment compliance, and related health. Its field underwriting guide asks about diagnosis date, CPAP or BiPAP compliance, whether supplemental oxygen is required with the device, recent pulmonary function test results (FEV1 and FVC%), tobacco use, and concurrent respiratory disorders ^[47]. Independent guidance adds weight, BMI, cardiovascular health, and comorbidities as material factors ^[48].

Product features relevant to this buyer:

• Term durations of 10, 15, 20, 25, or 30 years with level premiums for the selected period ^[50].
• Conversion to permanent coverage without a new medical exam, subject to policy terms ^[52].
• An included terminal-illness accelerated death benefit, plus optional riders including disability waiver of premium, children's benefit, accidental death, and income protection ^[50].
• Trendsetter LB living benefit riders for chronic, critical, and terminal illness at no additional premium ^[54].
• Accelerated underwriting programs for certain applicants, with eligibility depending on age, face amount, prior underwriting history, and risk class ^[55].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Transamerica term life cost per month for a buyer with sleep apnea?
• What happens to Transamerica Trendsetter Super premiums after the initial level term ends?

No verified public premium exists for a sleep apnea applicant. OpenAI, Perplexity, Deepseek, and Grok all reported low pricing confidence and no verifiable quote for this profile ^[57]. One independent sample cited by Anthropic states a 40-year-old nonsmoking woman pays $37 per month for $500,000 in 20-year term coverage, 21% below the national average — but that sample is not sleep-apnea-specific and should be treated as illustrative only ^[61].

Known cost structure:

• Premium is determined by underwriting and the selected coverage amount, term, and risk class ^[57].
• Moderate or severe sleep apnea may produce higher premiums or table ratings; each table step is commonly described as adding roughly 25% above Standard ^[63].
• Optional riders may increase premium; no specific application, policy, or medical-exam fee was verified ^[57].
• Trendsetter Super premiums are initially level for the selected guarantee period but may increase annually afterward — after year 10 for a 10-year policy, year 15 for a 15-year policy, and so on ^[57].
• A two-year suicide limitation applies in most states, and product and rider availability varies by jurisdiction; the cited disclaimer excludes New York ^[57].
• A standard free-look period of roughly 10 to 30 days by state is described in platform-reported sources ^[66].

Best Suited For

Questions This Section Answers

• Who is Transamerica best suited for among sleep apnea life insurance buyers?
• Is Transamerica worth it for a buyer with mild, CPAP-treated sleep apnea?

Transamerica is best suited for applicants with mild or moderate sleep apnea that is treated, documented, and reasonably controlled. OpenAI's fit assessment lists applicants with mild or moderate treated and well-documented sleep apnea, buyers seeking 10- to 30-year term coverage, applicants who may qualify for simplified or accelerated underwriting, and buyers who value conversion or living-benefit features ^[67].

Anthropic adds buyers with an average height-to-weight ratio and well-managed comorbidities, and those prioritizing affordable term pricing over premium customer service ^[70]. Google's assessment is narrower: applicants with mild sleep apnea seeking a Standard rate class and a healthy height-to-weight ratio ^[72].

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Transamerica for life insurance with sleep apnea?
• Is Transamerica a poor fit for severe or untreated sleep apnea?

Transamerica is probably not the best fit for applicants with severe, untreated, recently diagnosed, or poorly documented sleep apnea. OpenAI states severe sleep apnea may receive a heavily rated offer or decline under the cited guide ^[74]. Google reports severe sleep apnea frequently results in high table ratings from Table 2 to decline, and that using supplemental oxygen alongside CPAP is highly scrutinized and increases declination likelihood ^[75].

Other poor-fit profiles named across platforms: buyers whose principal goal is guaranteed acceptance or no underwriting ^[74]; applicants with multiple comorbidities such as obesity, cardiovascular disease, or diabetes who need the most favorable treatment for that combination ^[74]; buyers in New York, where Trendsetter Super is unavailable ^[79]; and consumers expecting above-average customer service — Anthropic cites an NAIC complaint index of 3.86, nearly four times the industry average of 1.0, and a J.D. Power score placing Transamerica 18th of 21 carriers ^[81].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Transamerica for severe or untreated sleep apnea?
• When should a sleep apnea buyer choose a different carrier than Transamerica?

Another carrier may be better in several defined situations.

• Severe, untreated, or CPAP-noncompliant sleep apnea: platforms named specialized impaired-risk or high-risk carriers as better positioned, including American Amicable, Corebridge Financial, Pacific Life, and Prudential ^[84].
• Mild sleep apnea seeking Preferred Plus: Grok states Protective or similar carriers may be more aggressive on top classes ^[88].
• Guaranteed acceptance needed: Mutual of Omaha, AIG, or Fidelity Life simplified issue, or guaranteed-issue products with graded benefits and coverage caps, were named as alternatives ^[85].
• Coverage above $2 million without a medical exam: most carriers require exams above that threshold, and Anthropic reports Transamerica likely requires an exam for pre-existing conditions like sleep apnea above $1 million ^[90].
• New York residents: Trendsetter Super is unavailable; compare state-available competitors ^[92].
• Multiple comorbidities alongside sleep apnea: an independent broker comparing informal underwriting outcomes before submission may produce a better result than applying directly ^[94].

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with Transamerica before signing a sleep apnea life insurance policy?
• Will Transamerica require a sleep study or CPAP compliance download during underwriting?

Before applying, confirm the following with a licensed agent or directly with Transamerica:

1. For your exact AHI, apnea type, diagnosis date, treatment method, and CPAP or oral-appliance compliance, what underwriting class is realistically expected? ^[96]
2. Will Transamerica require a paramedical exam, attending-physician statement, sleep-study report, CPAP compliance download, or cardiology records? ^[96]
3. Does the selected product offer no-medical-exam or accelerated underwriting for your age, state, coverage amount, and medical history — and does the $2 million ceiling or the lower bulletin limits apply? ^[98]
4. Are Trendsetter Super, Trendsetter LB, or another current Transamerica term form available in your state? ^[100]
5. What are the exact premiums during and after the initial level-premium period? ^[100]
6. What table rating, exclusion, postponement, or decline outcome applies if treatment compliance is incomplete or the condition is severe? ^[96]
7. Which riders are available, what do they cost, and what exclusions or eligibility rules apply? ^[103]
8. What are the conversion deadline, eligible permanent products, conversion pricing basis, and medical-underwriting requirements? ^[105]
9. Should an independent broker obtain informal underwriting opinions from multiple carriers before submitting a formal application? ^[106]

Final AI Consensus Verdict

Transamerica is a good fit for a sleep-apnea applicant seeking conventional term life insurance with documented, treated, reasonably controlled disease. Its published underwriting guide is unusually relevant because it gives sleep-apnea-specific potential outcomes, and its term portfolio offers useful duration and conversion choices. It is not demonstrably the best carrier for every sleep-apnea profile: severe, untreated, poorly documented, or medically complex applicants should compare multiple insurers before applying, and all no-exam, pricing, state-availability, and final rate-class assumptions should be verified directly. Four of seven platforms rated the fit good; three rated it mixed.

How This Review Was Produced

This review synthesizes fit-research responses from seven AI platforms — Anthropic, Deepseek, Google, Grok, Kimi, OpenAI, and Perplexity — each asked which life insurance carriers are generally worth considering for applicants with sleep apnea and why. Four of the seven platforms named Transamerica during the ranking stage. The report evaluates Transamerica only for the Life Insurance for Sleep Apnea use case; it is not a broad company review. All platform responses are platform-reported and were not independently verified by the writer stage. The consensus index for this category is available at Life Insurance for Sleep Apnea, and the broader directory is at life insurance.

Methodology Limitations

• The run research date is 2026-09-22. Platform-reported research dates are provenance metadata and do not independently prove freshness. Deepseek's response is dated 2026-01-15, eight months earlier than the run date, and Deepseek's research was conducted without search enabled.
• Platform mentions count only platforms that named Transamerica during ranking discovery; all seven platforms evaluated fit, but only four named the entity in the ranking stage.
• Conflicting product names, pricing, and capabilities were not resolved by guessing. The 20–40 year term claim, the Foundation Series product reference, the $2 million no-exam ceiling versus lower bulletin limits, and the AM Best rating discrepancy (A versus A+) remain unresolved in the reviewed sources.
• The supplied URLs were collected from platform responses and were not independently validated by the writer stage.
• Citations are platform-reported evidence, not independently verified facts. Claims from platforms without search capability require explicit verification before being described as current facts.
• Public underwriting materials provide potential risk classes, not binding offers. No public, buyer-specific premium can be validated without a formal quote.
• The sources reviewed do not establish whether current 2026 product forms, rates, accelerated-underwriting rules, or state availability differ from the cited materials.